Agaplesion Evangelisches Krankenhaus Mittelhessen gGmbH

The medical center is at the forefront of respiratory medicine, with a particular focus on idiopathic pulmonary fibrosis (IPF). This chronic and progressive lung disease is characterized by the thickening and scarring of lung tissue, leading to severe respiratory issues.

• Idiopathic Pulmonary Fibrosis (IPF)
• Advanced Therapeutics
• Patient-Centric Care

Through its involvement in the WHISTLE-PF Trial, the center is contributing to the development of innovative treatments aimed at improving the quality of life for patients with IPF. The trial evaluates the safety and efficacy of novel therapeutic agents, offering hope for more effective management of this challenging condition.